G
GlaxoSmithKline
Canadian residents who took the diabetes medication Avandia may be eligible for cash from a $6.75 million class action settlement.
ClosedCanada-wideClaim status: Claim window closedPayout: Closed settlementNo longer claimable
About this settlement
Class action settlement for Canadian residents who took Avandia and suffered heart-related injuries.
This settlement resolves claims that the diabetes medication Avandia caused life-threatening side effects including heart attacks and heart failure for Canadian users.
Who qualifies
- Canadian residents who took Avandia for diabetes treatment.
- Those who experienced heart attacks or heart failure linked to Avandia use.
Closed settlement
Claim status: Claim window closed